Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease

Clinical Endocrinology

Volumn 68, Issue 6, 2008, Pages 982-987

  Bufalo, Natássia E ^a   Santos, Roberto B ^b   Cury, Adriano N ^c   Andrade, Renato A ^a   Morari, Joseane ^a   Morari, Elaine C ^a   Leite, Janaína L ^a   Monte, Osmar ^c   Romaldini, João H ^b   Ward, Laura S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^c Department of Medicine   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PROTEIN P53;

APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA REPAIR; ENDOCRINE OPHTHALMOPATHY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 43949134907     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03121.x     Document Type: Article

References (41)

1. 1 Weetman, A.P. (2003) Autoimmune thyroid disease: propagation and progression. European Journal of Endocrinology, 148, 1–9.
2. 2 Prummel, M.F., Strieder, T. & Wiersinga, W.M. (2004) The environment and autoimmune thyroid diseases. European Journal of Endocrinology, 150, 605–618.
3. 3 Brix, T.H., Kyvik, K.O., Christensen, K. & Hegedus, L. (2001) Evidence for a major role of heredity in Graves’ disease: a population‐based study of two Danish twin cohorts. Journal of Clinical Endocrinology and Metabolism, 86, 930–934.
4. 4 Tait, K.F. & Cough, S.C.L. (2003) The genetics of autoimmune endocrine disease. Clinical Endocrinology, 59, 1–11.
5. 5 Tomer, Y. & Davies, T.F. (2003) Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Reviews, 24, 694–717.
6. 6 Miller, M.C. 3rd, Mohrenweiser, H.W. & Bell, D.A. (2001) Genetic variability in susceptibility and response to toxicants. Toxicology Letters, 120, 269–280.
7. 7 Kim, J.H., Lee, K.H., Yoo, D.H., Kang, D., Cho, S.H. & Hong, Y.C. (2007) GSTM1 and TNF‐α gene polymorphisms and relations between blood lead and inflammatory markers in a non‐occupational population. Mutation Research, 629, 32–39.
8. 8 Kim, J.H., Park, S.G., Lee, K.H., Choi, J.H., Ha, E.H., Myung, S.K. & Hong, Y.C. (2006) GSTM1 and GSTP1 polymorphisms as potential factors for modifying the effect of smoking on inflammatory response. Journal of Korean Medical Science, 21, 1021–1027.
9. 9 Stavropoulou, C., Korakaki, D., Rigana, H., Voutsinas, G., Polyzoi, M., Georgakakos, V.N., Manola, K.N., Karageorgiou, C.E. & Sambani, C. (2007) Glutathione‐S‐transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study. European Journal of Neurology, 14, 572–574.
10. 10 Kuwabara, S. (2007) Guillain–Barré syndrome. Current Neurology and Neuroscience Reports, 7, 57–62.
11. 11 Morinobu, S., Morinobu, A., Kanagawa, S., Hayashi, N., Nishimura, K. & Kumagai, S. (2006) Glutathione S‐transferase gene polymorphisms in Japanese patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 24, 268–273.
12. 12 Vestergaard, P. (2002) Smoking and thyroid disorders–a meta‐analysis. European Journal of Endocrinology, 146, 153–161.
13. 13 Strange, R.C., Jones, P.W. & Fryer, A.A. (2000) Glutathione S‐transferase: genetics and role in toxicology. Toxicology Letters, 112–113, 357–363.
14. 14 Hayes, J.D. & Strange, R.C. (2000) Glutathione S‐transferase polymorphisms and their biological consequences. Pharmacology, 61, 154–166.
15. 15 Knudsen, L.E., Loft, S.H. & Autrup, H. (2001) Risk assessment: the importance of genetic polymorphisms in man. Mutation Research, 482, 83–88.
16. 16 Johansson, A.S., Stenberg, G., Widersten, M. & Mannervik, B. (1998) Structure–activity relationships and thermal stability of human glutathione transferase P1‐1 governed by the H‐site residue 105. Journal of Molecular Biology, 278, 687–698.
17. 17 Hu, X., Ji, X., Srivastava, S.K., Xia, H., Awasthi, S., Nanduri, B., Awasthi, Y.C., Zimniak, P. & Singh, S.V. (1997) Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S‐transferase P1‐1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Archives of Biochemistry and Biophysics, 345, 32–38.
18. 18 Coecke, S., Vanhaecke, T., Foriers, A., Phillips, I.R., Vercruysse, A., Shephard, E.A. & Rogiers, V. (2000) Hormonal regulation of glutathione S‐transferase expression in co‐cultured adult rat hepatocytes. Journal of Endocrinology, 166, 363–371.
19. 19 Trell, L., Korsgaard, R., Janzon, L. & Trell, E. (1985) Distribution and reproducibility of aryl hydrocarbon hydroxylase inducibility in a prospective population study of middle‐aged male smokers and nonsmokers. Cancer, 56, 1988–1994.
20. 20 Wu, M.T., Lee, J.M., Wu, D.C., Ho, C.K., Wang, Y.T., Lee, Y.C., Hsu, H.K. & Kao, E.L. (2002) Genetic polymorphisms of cytochrome P4501A1 and oesophageal aquamous‐cell carcinoma in Taiwan. British Journal of Cancer, 87, 529–532.
21. 21 Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. & Watanabe, J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Letters, 263, 131–133.
22. 22 Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F. & Soddu, S. (2007) MDM2‐regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage‐induced apoptosis. Molecular Cell, 25, 739–750.
23. 23 Karp, G. (2002) Cell and Molecular Biology: Concepts and Experiments, 3rd edn. John Wiley & Sons, New York, NY.
24. 24 Duke, R.C., Ojcius, D.M. & Young, J.D. (1996) Cell suicide in health and disease. Scientific America, 275, 80–87.
25. 25 Lee, Y.H., Rho, Y.H., Choi, S.J., Ji, J.D. & Song, G.G. (2005) The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus. Lupus, 14, 842–845.
26. 26 Lee, Y.H., Kim, Y.R., Ji, J.D., Sohn, J. & Song, G.G. (2001) p53 codon 72 polymorphism and rheumatoid arthritis. Journal of Rheumatology, 28, 2392–2394.
27. 27 Morari, E.C., Leite, J.L., Granja, F., Assumpcao, L.V.M. & Ward, L.S. (2002) The null genotype of glutathione S‐transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiology Biomarkers and Prevention, 11, 1485–1488.
28. 28 Granja, F., Morari, J., Morari, E.C., Correa, L.A., Assumpção, L.A. & Ward, L.S. (2004) GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letters, 209, 129–137.
29. 29 Bufalo, N.E., Leite, J.L., Guilhen, A.C., Morari, E.C., Granja, F., Assumpção, L.V.M. & Ward, L.S. (2006) Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocrine Related Cancer, 13, 1185–1193.
30. 30 Mourits, M.P., Prummel, M.F., Wiersinga, W.M. & Koornneef, L. (1997) Clinical Activity Score as a guide in the management of patients with Graves’ ophthalmopathy. Clinical Endocrinology, 47, 9–14.
31. 31 Morari, E.C., Lima, A.B., Bufalo, N.E., Leite, J.L., Granja, F. & Ward, L.S. (2006) Role of glutathione‐S‐transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. Journal of Cancer Research and Clinical Oncology, 132, 521–528.
32. 32 Gilbertson, M.K., Haffner, G.D., Drouillard, K.G., Albert, A. & Dixon, B. (2003) Immunosuppression in the northern leopard frog (Rana pipiens) induced by pesticide exposure. Environmental Toxicology and Chemistry, 22, 101–110.
33. 33 Nichenametla, S., South, E. & Exon, J. (2004) Interaction of conjugated linoleic acid, sphingomyelin, and butyrate on formation of colonic aberrant crypt foci and immune functions in rats. Journal of Toxicology and Environmental Health. Part A, 67, 469–481.
34. 34 Aune, T.M., Maas, K., Parker, J., Moore, J.H. & Olsen, N.J. (2004) Profiles of gene expression in human autoimmune disease. Cell Biochemistry and Biophysics, 40, 81–96.
35. 35 Kita, H., He, X.S. & Gershwin, M.E. (2004) Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis. Annals of Medicine, 36, 72–80.
36. 36 Fourneau, J.M., Bach, J.M., Van Endert, P.M. & Bach, J.F. (2004) The elusive case for a role of mimicry in autoimmune diseases. Molecular Immunology, 40, 1095–1102.
37. 37 Vestergaard, P. (2002) Smoking and thyroid disorders–a meta‐analysis. European Journal of Endocrinology, 146, 153–161.
38. 38 Cao, Z., Hardej, D., Trombetta, L.D. & Li, Y. (2003) The role of chemically induced glutathione and glutathione S‐transferase in protecting against 4‐hydroxy‐2‐nonenal‐mediated cytotoxicity in vascular smooth muscle cells. Cardiovascular Toxicology, 3, 165–177.
39. 39 Fenton, C.L., Patel, A., Tuttle, R.M. & Francis, G.L. (2000) Autoantibodies to p53 in sera of patients with autoimmune thyroid disease. Annals of Clinical Laboratory and Science, 30, 179–183.
40. 40 Dumont, P., Leu, J.I., Della Pietra, A.C. 3rd, George, D.L. & Murphy, M. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature Genetics, 33, 357–365.
41. 41 Wang, X.L. & Wang, J. (2005) Smoking–gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World Journal of Surgery, 29, 344–353.